TEMPUR-PEDIC REPORTS SECOND QUARTER EARNINGS
| | | - Gross Profit Margin Increases 220 Basis Points to 46.6% |
LEXINGTON, KY, July 16, 2009 – Tempur-Pedic International Inc. (NYSE: TPX), the leading manufacturer, marketer and distributor of premium mattresses and pillows worldwide, today announced financial results for the second quarter ended June 30, 2009. The Company also confirmed its financial guidance for 2009.
SECOND QUARTER FINANCIAL SUMMARY
| Earnings per share (EPS) were $0.22 per diluted share in the second quarter of 2009 as compared to $0.27 per diluted share in the second quarter of 2008. The Company reported net income of $16.9 million for the second quarter of 2009 as compared to net income of $20.2 million in the second quarter of 2008. |
| · | Net sales declined 22% to $185.2 million in the second quarter of 2009 from $238.7 million in the second quarter of 2008. On a constant currency basis, net sales declined 19%. Net sales in the domestic segment declined 19%, while international segment net sales declined 29%. On a constant currency basis, international segment net sales declined 19%. |
| · | Mattress sales declined 24% globally. Mattress sales declined 20% in the domestic segment and 31% in the international segment. On a constant currency basis, international mattress sales declined 21%. Pillow sales declined 17% globally. Pillow sales declined 12% domestically and 20% internationally. On a constant currency basis, international pillow sales declined 12%. |
| · | Gross profit margin was 46.6% as compared to 44.4% in the second quarter of 2008. The gross profit margin increased as a result of lower commodity costs, improved efficiencies in manufacturing and improved pricing, partially offset by fixed cost de-leverage related to lower production volumes. |
| · | Operating profit margin was 15.7% as compared to 15.2% in the second quarter of 2008. The Company reduced operating expenses by $12.5 million to $57.2 million in the second quarter of 2009 from $69.7 million in the second quarter of 2008. |
| · | Reflecting the Company’s continued focus on generating cash, the Company generated $39.5 million of operating cash flow in the second quarter of 2009. |
| · | During the quarter, the Company reduced Total debt by $31.0 million to $369.0 million and increased cash by $3.8 million to $25.0. As of June 30, 2009, the Company’s ratio of Funded debt to EBITDA was 2.29 times, well within the covenant in its credit facility, which requires that this ratio not exceed 3.00 times. For additional information about EBITDA and Funded debt (which are non-GAAP measures), please refer to the reconciliation and other information included in the attached schedule. |
Chief Executive Officer Mark Sarvary commented, “During the second quarter, our initiatives to drive sales and margins continued to show progress. Our productivity projects helped us expand gross margins with improvement compared to last year and last quarter. Our focus on cash flow continued to display the strength of our business model as we lowered debt $31 million during the quarter. We believe we are well positioned for growth when the economy recovers.”
2009 Financial Guidance
The Company confirmed its prior guidance ranges for EPS and net sales for full year 2009. The Company continues to expect EPS to range from $0.70 to $0.90 per diluted share. The Company continues to expect net sales to range from $700 million to $740 million. The Company noted its expectations are based on information available at the time of this release, and are subject to changing conditions, many of which are outside the Company’s control.
Conference Call Information
Tempur-Pedic International will host a live conference call to discuss financial results today, July 16, 2009 at 5:00 p.m. Eastern Time. The dial-in number for the conference call is 877-419-6593. The call is also being webcast and can be accessed on the investor relations section of the Company’s website, www.tempurpedic.com.
For those who cannot listen to the live broadcast, a telephone replay of the call will be available from July 16, 2009 at 8:00 p.m. Eastern Time through July 23, 2009. To listen to the replay, dial 888-203-1112, participant code 7809604.
Forward-looking Statements
This release contains "forward-looking statements,” within the meaning of federal securities laws, which include information concerning one or more of the Company's plans, objectives, goals, strategies, and other information that is not historical information. When used in this release, the words "estimates," "expects," "anticipates," "projects," "plans," "intends," "believes," and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements include, without limitation, statements relating to the Company’s positioning for future growth and the Company’s expectations regarding net sales and earnings per share for 2009. All forward looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct.
There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the Company's control, could cause actual results to differ materially from those expressed as forward-looking statements. These risk factors include general economic, financial and industry conditions, particularly in the retail sector, as well as consumer confidence and the availability of consumer financing; the Company’s ability to reduce expenses to align with reduced sales levels; uncertainties arising from global events; the effects of changes in foreign exchange rates on the Company’s reported earnings; consumer acceptance of the Company’s products; industry competition; the efficiency and effectiveness of the Company’s advertising campaigns and other marketing programs; the Company’s ability to increase sales productivity within existing retail accounts and to further penetrate the Company’s domestic retail channel, including the timing of opening or expanding within large retail accounts; the Company’s ability to address issues in certain underperforming international markets; the Company’s ability to continuously improve and expand its product line, maintain efficient, timely and cost-effective production and delivery of its products, and manage its growth; changes in foreign tax rates, including the ability to utilize tax loss carry forwards; and rising commodity costs. Additional information concerning these and other risks and uncertainties are discussed in the Company's filings with the Securities and Exchange Commission, including without limitation the Company's annual report on Form 10-K under the headings "Special Note Regarding Forward-Looking Statements" and "Risk Factors." Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements for any reason, including to reflect events or circumstances after the date on which such statements are made or to reflect the occurrence of anticipated or unanticipated events or circumstances.
About the Company
Tempur-Pedic International Inc. (NYSE: TPX) manufactures and distributes mattresses and pillows made from its proprietary TEMPUR® pressure-relieving material. It is the worldwide leader in premium and specialty sleep. The Company is focused on developing, manufacturing and marketing advanced sleep surfaces that help improve the quality of life for people around the world. The Company’s products are currently sold in over 70 countries under the TEMPUR® and Tempur-Pedic® brand names. World headquarters for Tempur-Pedic International is in Lexington, KY. For more information, visit http://www.tempurpedic.com or call 800-805-3635.
Investor Relations Contact:
Barry Hytinen
Vice President, Investor Relations and Financial Planning & Analysis
800-805-3635
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Income
(In thousands, except per common share amounts)
| | | Three Months Ended | | | | | | Six Months Ended | | | | |
| | | June 30, | | | | | | June 30, | | | | |
| | | 2009 | | | 2008 | | | Chg % | | | 2009 | | | 2008 | | | Chg % | |
| Net sales | | $ | 185,176 | | | $ | 238,661 | | | | (22)% | | | $ | 362,280 | | | $ | 485,883 | | | | (25)% | |
| Cost of sales | | | 98,845 | | | | 132,645 | | | | | | | | 194,088 | | | | 271,786 | | | | | |
| Gross profit | | | 86,331 | | | | 106,016 | | | | (19)% | | | | 168,192 | | | | 214,097 | | | | (21)% | |
| Selling and marketing expenses | | | 35,191 | | | | 44,787 | | | | | | | | 69,063 | | | | 97,950 | | | | | |
| General, administrative and other expenses | | | 21,978 | | | | 24,910 | | | | | | | | 44,086 | | | | 50,495 | | | | | |
| Operating income | | | 29,162 | | | | 36,319 | | | | (20)% | | | | 55,043 | | | | 65,652 | | | | (16)% | |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| Other income (expense), net: | | | | | | | | | | | | | | | | | | | | | | | | |
| Interest expense, net | | | (4,477 | ) | | | (5,645 | ) | | | | | | | (9,048 | ) | | | (13,336 | ) | | | | |
| Other income (expense), net | | | 270 | | | | (72 | ) | | | | | | | 618 | | | | (1,091 | ) | | | | |
| Total other expense | | | (4,207 | ) | | | (5,717 | ) | | | | | | | (8,430 | ) | | | (14,427 | ) | | | | |
| Income before income taxes | | | 24,955 | | | | 30,602 | | | | (19)% | | | | 46,613 | | | | 51,225 | | | | (9)% | |
| Income tax provision | | | 8,098 | | | | 10,374 | | | | | | | | 16,418 | | | | 17,483 | | | | | |
| Net income | | $ | 16,857 | | | $ | 20,228 | | | | (17)% | | | $ | 30,195 | | | $ | 33,742 | | | | (11)% | |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| Earnings per common share: | | | | | | | | | | | | | | | | | | | | | | | | |
| Basic | | $ | 0.23 | | | $ | 0.27 | | | | | | | $ | 0.40 | | | $ | 0.45 | | | | | |
| Diluted | | $ | 0.22 | | | $ | 0.27 | | | | | | | $ | 0.40 | | | $ | 0.45 | | | | | |
| Weighted average common shares outstanding: | | | | | | | | | | | | | | | | | | | | | | | | |
| Basic | | | 74,894 | | | | 74,740 | | | | | | | | 74,884 | | | | 74,665 | | | | | |
| Diluted | | | 75,493 | | | | 74,931 | | | | | | | | 75,036 | | | | 74,872 | | | | | |
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(In thousands)
| | | June 30, | | | December 31, | |
| | | 2009 | | | 2008 | |
| ASSETS | | | | | | |
| | | | | | | |
| Current Assets: | | | | | | |
| Cash and cash equivalents | | $ | 24,974 | | | $ | 15,385 | |
| Accounts receivable, net | | | 91,002 | | | | 99,811 | |
| Inventories | | | 51,570 | | | | 60,497 | |
| Prepaid expenses and other current assets | | | 11,675 | | | | 9,233 | |
| Deferred income taxes | | | 18,043 | | | | 11,888 | |
| Total Current Assets | | | 197,264 | | | | 196,814 | |
| Property, plant and equipment, net | | | 176,867 | | | | 185,843 | |
| Goodwill | | | 192,998 | | | | 192,569 | |
| Other intangible assets, net | | | 65,820 | | | | 66,823 | |
| Other non-current assets | | | 3,758 | | | | 4,482 | |
| Total Assets | | $ | 636,707 | | | $ | 646,531 | |
| | | | | | | | | |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | | | |
| | | | | | | | | |
| Current Liabilities: | | | | | | | | |
| Accounts payable | | $ | 38,496 | | | $ | 41,355 | |
| Accrued expenses and other current liabilities | | | 78,365 | | | | 65,316 | |
| Income taxes payable | | | 3,061 | | | | 7,783 | |
| Total Current Liabilities | | | 119,922 | | | | 114,454 | |
| Long-term debt | | | 369,000 | | | | 419,341 | |
| Deferred income taxes | | | 28,888 | | | | 28,371 | |
| Other non-current liabilities | | | 9,711 | | | | 11,922 | |
| Total Liabilities | | | 527,521 | | | | 574,088 | |
| Total Stockholders’ Equity | | | 109,186 | | | | 72,443 | |
| Total Liabilities and Stockholders’ Equity | | $ | 636,707 | | | $ | 646,531 | |
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
(In thousands)
| | | Six Months Ended | |
| | | June 30, | |
| | | 2009 | | | 2008 | |
| CASH FLOWS FROM OPERATING ACTIVITIES: | | | | | | |
| Net income | | $ | 30,195 | | | $ | 33,742 | |
| Adjustments to reconcile net income to net cash provided by operating activities: | | | | | | | | |
| Depreciation and amortization | | | 15,514 | | | | 16,685 | |
| Amortization of stock-based compensation | | | 4,093 | | | | 4,041 | |
| Amortization of deferred financing costs | | | 345 | | | | 714 | |
| Bad debt expense | | | 3,864 | | | | 3,439 | |
| Deferred income taxes | | | (6,148 | ) | | | (958 | ) |
| Foreign currency adjustments | | | 193 | | | | 524 | |
| (Gain) Loss on sale of equipment and other | | | (45 | ) | | | 345 | |
| Changes in operating assets and liabilities | | | 17,439 | | | | 37,776 | |
| Net cash provided by operating activities | | | 65,450 | | | | 96,308 | |
| | | | | | | | | |
| CASH FLOWS FROM INVESTING ACTIVITIES: | | | | | | | | |
| Purchases of property, plant and equipment | | | (4,728 | ) | | | (6,328 | ) |
| Acquisition of business, net of cash acquired | | | — | | | | (1,522 | ) |
| Other | | | (155 | ) | | | (411 | ) |
| Net cash used by investing activities | | | (4,883 | ) | | | (8,261 | ) |
| | | | | | | | | |
| CASH FLOWS FROM FINANCING ACTIVITIES: | | | | | | | | |
| Proceeds from long-term revolving credit facility | | | 83,797 | | | | 70,732 | |
| Repayments of long-term revolving credit facility | | | (133,036 | ) | | | (57,244 | ) |
| Repayments of long-term debt | | | — | | | | (1,359 | ) |
| Repayment of Series A Industrial Revenue Bonds | | | — | | | | (57,785 | ) |
| Proceeds from issuance of common stock | | | — | | | | 695 | |
| Excess tax benefit from stock based compensation | | | — | | | | 366 | |
| Dividend paid to stockholders | | | — | | | | (11,946 | ) |
| Other | | | — | | | | (14 | ) |
| Net cash used by financing activities | | | (49,239 | ) | | | (56,555 | ) |
| NET EFFECT OF EXCHANGE RATE CHANGES ON CASH | | | (1,739 | ) | | | 3,546 | |
| Increase in cash and cash equivalents | | | 9,589 | | | | 35,038 | |
| CASH AND CASH EQUIVALENTS, beginning of period | | | 15,385 | | | | 33,315 | |
| CASH AND CASH EQUIVALENTS, end of period | | $ | 24,974 | | | $ | 68,353 | |
Summary of Channel Sales
The Company generates sales through four distribution channels: retail, direct, healthcare and third party. The retail channel sells to furniture, specialty and department stores globally. The direct channel sells directly to consumers. The healthcare channel sells to hospitals, nursing homes, healthcare professionals and medical retailers. The third party channel sells to distributors in countries where Tempur-Pedic International does not operate its own distribution company.
The following table highlights net sales information, by channel and by segment, for the second quarter of 2009 compared to 2008:
| (In thousands) | |
| | CONSOLIDATED | | DOMESTIC | | INTERNATIONAL | |
| | Three Months Ended | | Three Months Ended | | Three Months Ended | |
| | June 30, | | June 30, | | June 30, | |
| | 2009 | | | 2008 | | 2009 | | | 2008 | | 2009 | | | 2008 | |
| Retail | $ | 155,575 | | | $ | 199,323 | | $ | 105,576 | | | $ | 130,069 | | $ | 49,999 | | | $ | 69,254 | |
| Direct | | 10,785 | | | | 13,527 | | | 9,428 | | | | 11,328 | | | 1,357 | | | | 2,199 | |
| Healthcare | | 8,261 | | | | 12,556 | | | 2,686 | | | | 4,501 | | | 5,575 | | | | 8,055 | |
| Third Party | | 10,555 | | | | 13,255 | | | 3,054 | | | | 2,603 | | | 7,501 | | | | 10,652 | |
| Total | $ | 185,176 | | | $ | 238,661 | | $ | 120,744 | | | $ | 148,501 | | $ | 64,432 | | | $ | 90,160 | |
Summary of Product Sales
A summary of net sales by product is reported below:
| (In thousands) | |
| | CONSOLIDATED | | DOMESTIC | | INTERNATIONAL | |
| | Three Months Ended | | Three Months Ended | | Three Months Ended | |
| | June 30, | | June 30, | | June 30, | |
| | 2009 | | | 2008 | | 2009 | | | 2008 | | 2009 | | | 2008 | |
| Mattresses | $ | 124,344 | | | $ | 163,634 | | $ | 86,300 | | | $ | 108,369 | | $ | 38,044 | | | $ | 55,265 | |
| Pillows | | 24,006 | | | | 28,877 | | | 11,029 | | | | 12,583 | | | 12,977 | | | | 16,294 | |
| Other | | 36,826 | | | | 46,150 | | | 23,415 | | | | 27,549 | | | 13,411 | | | | 18,601 | |
| Total | $ | 185,176 | | | $ | 238,661 | | $ | 120,744 | | | $ | 148,501 | | $ | 64,432 | | | $ | 90,160 | |
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
EBITDA to Net Income and Funded debt to Total debt
Non-GAAP Measures
(In thousands)
The Company provides information regarding EBITDA and Funded debt which are not recognized terms under GAAP (Generally Accepted Accounting Principles) and do not purport to be alternatives to Net income as a measure of operating performance or Total debt. Because not all companies use identical calculations, these presentations may not be comparable to other similarly titled measures of other companies. A reconciliation of EBITDA to the Company’s Net income and reconciliation of Funded debt to Total debt are provided below. Management believes that the use of EBITDA and Funded debt provides investors with useful information with respect to the terms of the Company’s credit facility.
Reconciliation of EBITDA to Net income
The following table sets forth the reconciliation of the Company’s reported Net income to the calculation of EBITDA for each of the three months ended September 30, 2008, December 31, 2008, March 31, 2009 and June 30, 2009, as well as the twelve months ended June 30, 2009:
| | Three Months Ended | | | Twelve Months Ended | |
| | September 30, 2008 | | | December 31, 2008 | | | March 31, 2009 | | | June 30, 2009 | | | June 30, 2009 | |
| | | | | | | | | | | | | | | |
| GAAP Net income | $ | 24,071 | | | $ | 1,055 | | | $ | 13,338 | | | $ | 16,857 | | | $ | 55,321 | |
| Plus: | | | | | | | | | | | | | | | | | | | |
| Interest expense | | 6,294 | | | | 5,493 | | | | 4,571 | | | | 4,477 | | | | 20,835 | |
| Income taxes | | 12,622 | | | | 18,449 | | | | 8,320 | | | | 8,098 | | | | 47,489 | |
| Depreciation & amortization | | 10,222 | | | | 9,849 | | | | 9,630 | | | | 9,977 | | | | 39,678 | |
| | | | | | | | | | | | | | | | | | | | |
| EBITDA | $ | 53,209 | | | $ | 34,846 | | | $ | 35,859 | | | $ | 39,409 | | | $ | 163,323 | |
Reconciliation of Funded debt to Total debt
The following table sets forth the reconciliation of the Company’s reported Total debt to the calculation of Funded debt as of June 30, 2009:
| | | As of | |
| | | June 30, 2009 | |
| | | | |
| GAAP basis Total debt | | $ | 369,000 | |
| Plus: | | | | |
| Letters of credit outstanding | | | 4,995 | |
| Funded debt | | $ | 373,995 | |
Calculation of Funded debt to EBITDA
| | | As of | |
| | | June 30, 2009 | |
| | | | |
| | | | |
| Funded debt | | $ | 373,995 | |
| EBITDA | | | 163,323 | |
| | | 2.29 times | |
